Latest Breaking News On - Shenzhen qianhai development zone - Page 1 : comparemela.com

/PRNewswire/ OncoVent Co., Ltd. ("OncoVent"), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"),.

Hong kongUnited statesT ai peiCalvin tsaiTao hanCytovance biologics incEuropean medicines agencyPrnewswire oncovent co ltdShenzhen qianhai development zoneOrient europharma co ltdOncovent co ltdTaipei exchangeShenzhen hepalink pharmaceutical group co ltdDrug administrationOrphan drug designationsChief executive officer